| SVUIX | VMVAX | SVUIX / VMVAX | |
| Total Expense Ratio | 0.92 | 0.07 | 1,314% |
| Annual Report Gross Expense Ratio | 0.99 | 0.07 | 1,414% |
| Fund Existence | 18 years | 15 years | - |
| Gain YTD | 12.092 | 16.197 | 75% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000000 | 3000 | 66,667% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 296M | 37.2B | 1% |
| Annual Yield % from dividends | 0.69 | 1.88 | 37% |
| Returns for 1 year | 3.65 | 22.83 | 16% |
| Returns for 3 years | -40.36 | 44.35 | -91% |
| Returns for 5 years | -58.79 | 47.43 | -124% |
| Returns for 10 years | -51.20 | 127.15 | -40% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BIEMX | 19.16 | 0.74 | +4.02% |
| William Blair Emerging Mkts Growth R6 | |||
| FFARX | 17.90 | N/A | N/A |
| Franklin Global Allocation R | |||
| FIGSX | 19.88 | N/A | N/A |
| Fidelity Series International Growth | |||
| RTSGX | 5.44 | N/A | N/A |
| Transamerica Small Cap Growth R6 | |||
| MGOCX | 32.54 | -0.58 | -1.75% |
| NYLI WMC Enduring Capital Class C | |||